PRNewsWire
30 Mar 2026, 22:32 UTC · 24w ago
Verdict
Headline takes no side. We score DBD +0.60 — strongly bullish.
+0.60strongly bullish
More positive than 70% of ticker scores this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More negative than 81% of ticker scores this week
The company is being removed from the S&P SmallCap 600 index.
More negative than 81% of ticker scores this week
The company is being removed from the S&P SmallCap 600 because its market capitalization is no longer representative.
More positive than 42% of ticker scores this week
Completing a spin-off of Versigent while maintaining its position in the S&P 500 is generally a neutral to slightly positive strategic move.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
6d ago
−14.6%
Price is moving against the score
$62.86 vs $73.60 close before publication (Mar 30) · not market-adjusted
DBD chart →
